Utilisation and Determinants of Epidermal Growth Factor Receptor Mutation Testing in Patients with Non-small Cell Lung Cancer in Routine Clinical Practice: A Global Systematic Review
ConclusionsThe uptake of EGFR mutation testing of patients with NSCLC is suboptimal in many parts of the world. Incomplete uptake of testing is fuelled by selective testing referral practices, sample limitations, and funding constraints.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Canada Health | Cancer | Cancer & Oncology | Cardiology | China Health | Databases & Libraries | Germany Health | Heart | Insurance | Lung Cancer | New Zealand Health | Non-Small Cell Lung Cancer | Norway Health | Radiation Therapy | Science | Smokers | Spain Health | Study | Sweden Health | Websites